Therapeutic Use (Phase IV)

1,197 trials 558 recruiting

Filter these 1,197 trials by condition, country, sponsor and more.

Open in Search →

Avoiding Risks of Thrombosis and bleeding in Surgery (ARTS) trial Recruiting

2023-508147-43-00 Venous thromboembolism (in surgical patients) 2024-05-31
Anti-viral action against Type 1 diabetes autoimmunity GPPAD-05-AVAnT1A Recruiting

2023-507348-35-00 Risk for Type 1 Diabetes 2024-05-30
Comparison of Vedolizumab treatment to Adalimumab dose intensification in Crohn’s disease patients with loss of response or biomarker activi… Recruiting

2023-508154-25-00 Crohn's disease 2024-05-27
The efficacy of the use of Cellular Matrix / A-CP-HA Kit (combination of autologous platelet-rich plasma and non-cross-linked hyaluronic aci… Recruiting

2023-507200-31-00 genitourinary syndrome of menopause 2024-05-24
Pro-RAPID Recruiting

2023-507352-72-00 Crohn's Disease 2024-05-24
Immunosuppressive Drugs and Gut Microbiome: Pharmacokinetic- and Microbiome Diversity Effects Recruiting

2023-510486-10-00 Kidney transplantation 2024-05-22
Renal Outcomes in the early use of vasopressin in the treatment of septic shock Recruiting

2023-509071-16-00 Septic shock 2024-05-22
PEPPER-trial Recruiting

2023-507763-18-01 Placenta previa, preterm birth 2024-05-21
The effect of denosumab on muscle and strength and insulin sensitivity Recruiting

2024-510637-18-00 Postmenopausal osteoporosis 2024-05-21
PILOT STUDY ON THE EFFECTIVENESS OF CHOLINE ALFOSCERATE IN THE UNDER THRESHOLD DEPRESSION OF THE ELDERLY Recruiting

2025-520899-25-00 Under threshold depression of the elderly. 2024-05-17
EFFECT OF THE USE OF DAPAGLIFLOZIN IN DIURESIS, NATRIURIESIS AND IN ULTRAFILTRATION AND PERITONEAL ELIMINATION OF SODIUM, IN PATIENTS WITH R… Recruiting

2023-505571-78-00 REFRACTORY HEART FAILURE 2024-05-16
PROMISE Recruiting

2023-505626-34-01 Chronic kidney disease 2024-05-16
Antibiotic THErapy iN vIral Airway iNfections (ATHENIAN): An open labelled randomized controlled pragmatic trial to evaluate the efficacy an… Recruiting

2023-509286-20-00 Viral respiratory tract infection 2024-05-15
Randomized, placebo-controlled, double-blind study to evaluate the efficacy of 2LPAPI® on the clearance of high-risk oncogenic HPV genital i… Recruiting

2024-513969-39-00 Human Papillomavirus infection 2024-05-09
Comparison of PENG block and lumbar plexus block in terms of postoperative analgesia and mobilization for fast track primary hip arthroplast… Recruiting

2023-507506-14-01 Total Hip Arthroplasty 2024-05-08
Metamizole as pain treatment in patients with chronic pancreatitis, a multicenter, randomized, double-blind, placebo-controlled, superiority… Recruiting

2023-504143-14-00 Chronic pancreatitis 2024-05-02
Budesonide as a treatment for inflammation in stomach complaints. Recruiting

2024-517035-43-00 Functional Dyspepsia 2024-05-01
Sterile allogeneic spongioflex® allografts as partial meniscal replacement after incomplete meniscal loss, an investigator initiated trial Recruiting

2023-508271-36-00 incomplete meniscal loss 2024-04-30
The LiLa-Bipolar RCT Recruiting

2023-509607-32-00 Bipolar Disorder, Type II 2024-04-29
Effect of infLuenza vaccInation after Myocardial INfArction on cardiac inflammaTory responsE - a randomized, double-blind, placebo-controlle… Recruiting

2023-505361-86-00 Myocardial infarction 2024-04-12
VACCINE EFFECTIVENESS OF 20-VALENT PNEUMOCOCCAL CONJUGATE VACCINE AGAINST VACCINE-TYPE CAP USING A TEST-NEGATIVE DESIGN Recruiting

2023-507293-40-00 VACCINE-TYPE RADIOLOGICALLY-CONFIRMED COMMUNITY-ACQUIRE 2024-04-11
Use of determination of drug levels to optimize pharmacotherapy of heart failure Recruiting

2023-506283-13-00 Chronic heart failure with reduced ejection fraction 2024-04-09
A Phase IV, Post-Authorization Safety Study to Investigate the Long-Term Safety of lutetium (177Lu) vipivotide tetraxetan in Adult Participa… Recruiting

2023-503208-94-00 Prostate cancer 2024-04-04
EVALUATION OF THE EFFICACY OF INHALATORY SEDATION IN COMPARISON WITH CONVENTIONAL INTRAVENOUS SEDATION IN NEUROCRITIC PATIENTS Recruiting

2024-512077-27-00 NEUROCRITIC PATIENTS 2024-04-04